profile revealed positivity for anti-dsDNA, anti-Sm, anti-nucleosome, anti-U1RNP and anti-Ku antibodies in the male patient, while the female SLE patient showed positivity for anti-dsDNA and anti-Sm antibodies.
determination in a routine laboratory.
positivity has not been reported previously in eosinophilic fasciitis with any consistency, and rheumatoid factor is almost always negative.
9]/L Erythrocyte 10 mm/h sedimentation rate C-reactive protein 13 mg/L Antinuclear antibody
Negative Rheumatoid factor Negative Sodium 141 mmol/L Potassium 4.
In most populations, up to 75 per cent of individuals with positive antinuclear antibody
(ANA) tests do not have identifiable rheumatic disease (1).
Test results for HIV and antinuclear antibody
Immunology profile findings included positive antinuclear antibody
(ANA) and double-stranded DNA antibody.
In addition to a routine history and physical examination, the workup for DLE should include a complete blood count, antinuclear antibody
levels, anti-Ro, anti-La, hepatic and renal function tests, and urinalysis.
One of the autoantibody tests, the antinuclear antibody
(ANA) test, is standard for assessing SLE because it is positive in almost 100 percent of patients with the disease.
Findings on laboratory evaluations--including measurements of c- and p-antineutrophil cytoplasmic antibody (c-ANCA and p-ANCA), angiotensin-converting enzyme (ACE), antinuclear antibody
(ANA), erythrocyte sedimentation rate (ESR), sputum acid-fast bacilli (AFB), and a complete blood count--were normal.
An antinuclear antibody
score of [greater than or equal to] 1.
In general, all children with JRA are tested for antinuclear antibody
Other commercially-available EliA assays include Anti-Cardiolipin (aCL) IgG/IgM, Anti-B2-Glycoprotein 1 (anti-B2-GP1) IgG/IgM, Cyclic Citrullinated Peptide (CCP), tissue Transglutaminase (tTG) IgA/ IgG, Gliadin IgA/IgG, dsDNA, Antinuclear Antibody
Screen (Symphony), and ENA antibodies to the following antigens: Sm, U1RNP, RNP70, Ro, La, Scl-70, CENP and Jo-1.
Due to the presence of symmetric joint pain and morning stiffness for longer than one hour, acute-phase proteins including erythrocyte sedimentation rate and C-reactive protein, immunological tests including rheumatoid factor and anti-cyclic citrullinated peptide and antinuclear antibody